Subclinical myocardial damage after anthracycline chemotherapy in Japanese patients with breast cancer
Journal of Cardiology · 2024
DOI: 10.1016/j.jjcc.2024.03.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiology, 2024. Verfasst von Kenji Nakatsuma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Anthracyclines, Natriuretic Peptide, Brain, Troponin I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: Data on the incidence, timing, and severity of myocardial damage after anthracycline-based chemotherapy (AC) in Japanese patients with breast cancer are limited. METHOD: We evaluated cancer therapy-related cardiac dysfunction (CTRCD) in Japanese women with breast cancer (n = 51) after the first AC according to the definitions of the 2022 European Society of Cardiology onco-cardiology guideline, including assessment of high-sensitivity troponin I (TnI) and B-type natriuretic peptide (BNP) levels. RESULTS: CTRCD was detected in 67 % of the patients (3.9 %, 7.8 %, 9.8 %, 43 %, 37 %, 22 %, 20 %, and 9.8 % of patients at 1 week and 1, 2, 3, 6, 9, 12, and 15 months post-AC, respectively) without significant left ventricular ejection fraction reduction ( 26 pg/mL) were found in 43 % of patients, and elevated BNP levels (≥35 pg/mL) were observed in 22 % of patients during the follow-up period. CONCLUSIONS: Approximately two-thirds of the Japanese patients in this study experienced CTRCD, which was frequently observed at 3 or 6 months post-AC. However, all patients with CTRCD were diagnosed with mild asymptomatic CTRCD. Although, these patients were diagnosed with mild asymptomatic CTRCD, careful long-term follow-up will be required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: nei126@kuhp.kyoto-u.ac.jp.
- Department of Pharmacology, Shiga University of Medical Science, Shiga, Japan.
- Department of Breast Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
- Department of Data Science, National Cerebral and Cardiovascular Center, Osaka, Japan.
- Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Zitieren
APA
Nakatsuma, K., Ozasa, N., Ohno, M., Ishiguro, H., Minami, M., Nishi, E., Toi, M., Ono, K., & Kimura, T. (2024). Subclinical myocardial damage after anthracycline chemotherapy in Japanese patients with breast cancer. Journal of Cardiology. https://doi.org/10.1016/j.jjcc.2024.03.005
Vancouver
Nakatsuma K, Ozasa N, Ohno M, Ishiguro H, Minami M, Nishi E, et al. Subclinical myocardial damage after anthracycline chemotherapy in Japanese patients with breast cancer. Journal of Cardiology. 2024. doi:10.1016/j.jjcc.2024.03.005
BibTeX
@article{Nakatsuma2024,
author = {Nakatsuma, Kenji and Ozasa, Neiko and Ohno, Mikiko and Ishiguro, Hiroshi and Minami, Manabu and Nishi, Eiichiro and Toi, Masakazu and Ono, Koh and Kimura, Takeshi},
title = {Subclinical myocardial damage after anthracycline chemotherapy in Japanese patients with breast cancer},
journal = {Journal of Cardiology},
year = {2024},
doi = {10.1016/j.jjcc.2024.03.005}
}
EUVIMED